The Riverside Company, a global investment firm focused on the smaller end of the middle market, announces that Decera Clinical, a healthcare portfolio company, has invested in Onviv, Inc.

Founded in 2015, Onviv’s specialized lines of business include real-world intelligence, scientific communications, training expertise and stakeholder engagement that support informed decisions and drive meaningful outcomes for clients and patients.

This investment expands Decera Clinical’s capabilities across healthcare insights, scientific engagement and medical communications, combining complementary expertise, proprietary methodologies and longstanding industry relationships.

In line with Decera Clinical’s mission of ‘Scientific Activation,™’ the combined organization will be better positioned to help healthcare professionals and life sciences organizations navigate increasing complexity, accelerate innovation and translate evidence into action so better outcomes can be delivered for patients, providers and the communities they serve.

Read full press release here.